Impact of p53 immunostaining in predicting advanced or recurrent placental site trophoblastic tumors: A study of 12 cases
Authors:
- 1 September 2007
- journal article
- Published by Elsevier in Gynecologic Oncology
- Vol. 106 (3) , 446-452
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Placental site trophoblastic tumor: A study of 55 cases and review of the literature emphasizing factors of prognostic significanceGynecologic Oncology, 2006
- Placental site trophoblastic tumour: Clinical features and managementGynecologic Oncology, 2005
- Placental site trophoblastic tumor presenting as subaponeurotic metastasisInternational Journal of Gynecological Cancer, 2005
- Case of PSTT Treated with Chemotherapy Followed by Open Uterine Tumor Resection to Preserve FertilityGynecologic Oncology, 2002
- Epithelioid trophoblastic tumor of the uterus: Cytological and immunohistochemical observation of a casePathology International, 2002
- Placental Site Trophoblastic Tumor: A 17-Year Experience at the New England Trophoblastic Disease CenterGynecologic Oncology, 2001
- Placental Site Trophoblastic Tumor—Past as PrologueGynecologic Oncology, 2001
- Epithelioid Trophoblastic Tumor Metastatic to the Vagina: An Immunohistochemical and Ultrastructural StudyInternational Journal of Gynecological Pathology, 2000
- Failure of High-Dose Chemotherapy with Peripheral Blood Stem Cell Support for Refractory Placental Site Trophoblastic TumorGynecologic and Obstetric Investigation, 1999
- Recurrent Placental Site Trophoblastic Tumor of the Uterus: Clinical, Pathologic, Ultrastructural, and DNA Fingerprint StudyGynecologic Oncology, 1996